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Commentary
Medical education, cost and policy: 
what are the drivers for change? 
Medical education is expensive [1-3]. Worldwide 
spending on medical education is likely to exceed 
100 billion dollars annually [4]. Its expense has led 
many stakeholders to speculate on how costs could be 
reduced or how return on investment increased. In an 
ideal world such decisions would be made on sound 
evidence; however this is impossible in the absence of 
evidence. Even when evidence exists, practice in medical 
education is not always informed by it. Practice in 
medical education is as likely to be informed by history 
or tradition. Sometimes it will be informed by policy, 
but policy will not always be evidence based. So how is 
policy in the field of cost and value in medical education 
actually developed? The answer is that a range of drivers 
influence policy development: this short article outlines 
what some of these drivers are. Through developing a 
better understanding of the drivers, medical educators 
should be able to have a greater influence on policy. 
The first and foremost influence on policy in cost and 
value in medical education should be evidence-based 
knowledge. For example research evidence might 
demonstrate that online learning is a high value and low 
cost form of learning [5]. A policy of further investment 
in online learning would therefore be sound and 
justifiable. In this paradigm of evidence-based policy 
making, policy would not be built upon a single piece 
of evidence – rather it would be built on a number of 
research studies or ideally a systematic review or meta-
analysis. Since policy is rarely made by domain experts, 
evidence based knowledge must be presented to the 
policy-makers by the experts in terms that they will 
understand and that they can then action. Experts may 
differ or may have ideological biases of their own and 
this may influence the advice that they give. Leaders 
and their team of policy makers must have sound 
judgement to synthesise the knowledge that they are 
given and to develop sound policy from it. Ultimately 
choices must be evidence-based; choices must be 
explained in a comprehensible way for those who take 
decisions; and decision makers must be surrounded by 
staff who understand the evidence. Decision makers 
must also understand that different types of evidence 
might guide the policies in different circumstances (for 
example quantitative and qualitative evidence) and 
that consideration must be given to the problem of 
transferability of the evidence to different contexts.
Another influence on policy is what might at best 
be termed tradition and at worst inertia. For example 
the scientific evidence may suggest that educating 
healthcare professionals in primary care is both more 
effective and cost effective than educating them in 
tertiary care. However policy-makers may not direct 
a mass movement of learners from tertiary care to 
primary care by tomorrow. This is irrational in a 
purely evidence-based sense; however there may be 
many practical reasons why policy must lag somewhat 
behind the evidence. A tertiary care institution may 
have multiple functions – including clinical care, 
research and medical education. These functions are 
often inextricably interlinked – the academics at such 
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Medical education is expensive. Its expense has led many stakeholders to speculate on 
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institutions will often care for patients, teach students 
and carry out research. To withdraw funding for medical 
education and reallocate it elsewhere could destabilise 
the entire institution and put its clinical and research 
activities at risk. Some of the research activities might 
actually be income-generating for the institution – 
another financial reason not to endanger them. In the 
real world policy must move slowly and must sometimes 
be limited. 
A third influence on policy in cost and value in medical 
education will be people. However some individuals and 
groups may have more influence than others. Who has 
most sway will be strongly influenced by the prevailing 
policy culture of the time. Let’s look at a practical 
example. A series of research studies might demonstrate 
that a medical education assessment could be performed 
in a lower cost way without having any influence on the 
overall result. However all the stakeholders involved 
may not want to change. A small group of politically 
astute and clinically credible examiners might trump 
an army of educationalists, medical educationalists 
and medical educational economists. Examinees might 
have an even more limited say. All will be listened to 
but the culture of policy making at the institution will 
decide who is listened to most. 
A fourth influence on policy in this field is events, 
and mainly events that have gone wrong. Unfortunately 
there are all too many examples of this within healthcare 
and workforce education and development. One 
example might be the Medical Training Application 
Service (MTAS) scandal in 2007 in the UK [6]. MTAS 
was a new method to enable selection into specialty 
training – but it was beset by technology, confidentiality 
and educational challenges. Considerable time, effort 
and cost were expended in the process. Eventually it 
was closed and an enquiry ensued. The enquiry report 
and subsequent reports since still bear the mark of the 
problems that occurred in 2007 [7]. What went wrong 
has had far reaching consequences in issues as broad 
as competency based training and flexibility in medical 
education programmes.  It is questionable whether 
the scandal should have had such a long reaching 
influence but, regardless of the rights or wrongs of this 
phenomenon, there is no doubt but that it has.  
A fifth and final influence on emerging policy in 
medical education cost analysis is that of the media. 
One example is the introduction of revalidation in 
the UK. Revalidation is the system whereby doctors 
maintain their registration with the General Medical 
Council [8]. The process of revalidation is five yearly 
and relies on five successful annual appraisals which 
in turn rely on successful engagement with continuing 
professional development, quality improvement, 360 
appraisals and patient surveys (amongst other less 
onerous requirements). Various debates have taken 
place as to the utility of revalidation but few would 
disagree with the fact that revalidation is associated 
with significant costs. The purpose of revalidation is 
predominantly to help maintain standards but the 
mass media has portrayed revalidation in a different 
manner. It has reported on a number of major medical 
scandals involving medical murder, fraud, and doctors 
having inappropriate relationships with patients [9]. 
Revalidation has not been designed to prevent these 
occurrences and will not prevent them. However they 
have been used by elements of the media to justify its 
introduction. This is not to say that revalidation is not 
important or should not be introduced. There is little 
doubt but that it should have been introduced; however 
attempts should probably not be made to justify its 
expense in terms of outcomes that it will not prevent. 
But the media can develop a powerful narrative, with 
seemingly simple problems and seemingly simple 
cures. And the media can place considerable pressure 
on policy makers. Some people working in the media 
may have a personal agenda and this agenda may not 
necessarily coincide with the general public’s interests. 
In summary policy does not happen in a vacuum in 
any sphere of life. There is little question but that in a 
sphere that incurs a cost of 100 billion dollars annually 
there will be many influences on policy. As medical 
educators, we ignore these influences at our peril. It 
would be far wiser to leverage these factors to drive 
policy in the right direction. 
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